期刊
FASEB JOURNAL
卷 29, 期 12, 页码 4766-4771出版社
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.15-275404
关键词
MitoQ; tiron; reactive oxygen species; oxidative damage
资金
- Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom)
- Unilever (London, United Kingdom)
- MRC [MC_PC_13071] Funding Source: UKRI
- Medical Research Council [MC_PC_13071] Funding Source: researchfish
Redox homeostasis is maintained by the antioxidant defense system, which is responsible for eliminating a wide range of oxidants, including reactive oxygen species (ROS), lipid peroxides, and metals. Mitochondria-localized antioxidants are widely studied because the mitochondria, the major producers of intracellular ROS, have been linked to the cause of aging and other chronic diseases. Mitochondria-targeted antioxidants have shown great potential because they cross the mitochondrial phospholipid bilayer and eliminate ROS at the heart of the source. Growing evidence has identified mitochondria-targeted antioxidants, such as MitoQ and tiron, as potentially effective antioxidant therapies against the damage caused by enhanced ROS generation. This literature review summarizes the current knowledge on mitochondria-targeted antioxidants and their contribution to the body's antioxidant defense system. In addition to addressing the concerns surrounding current antioxidant strategies, including difficulties in targeting antioxidant treatment to sites of pathologic oxidative damage, we discuss promising therapeutic agents and new strategic approaches.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据